CHECKPOINT ATHERO: developing immune checkpoint-based therapeutics for atherosclerosis

Detalles Bibliográficos
Autores principales: Lutgens, E, Mulder, WJM, Monaco, C
Otros Autores: CHECKPOINT ATHERO consortium
Formato: Journal article
Lenguaje:English
Publicado: Oxford University Press 2023
_version_ 1826311921332125696
author Lutgens, E
Mulder, WJM
Monaco, C
author2 CHECKPOINT ATHERO consortium
author_facet CHECKPOINT ATHERO consortium
Lutgens, E
Mulder, WJM
Monaco, C
author_sort Lutgens, E
collection OXFORD
description
first_indexed 2024-03-07T08:19:54Z
format Journal article
id oxford-uuid:3f655ca0-9f50-4910-86d3-c1b4f2af2b3f
institution University of Oxford
language English
last_indexed 2024-03-07T08:19:54Z
publishDate 2023
publisher Oxford University Press
record_format dspace
spelling oxford-uuid:3f655ca0-9f50-4910-86d3-c1b4f2af2b3f2024-01-25T11:41:41ZCHECKPOINT ATHERO: developing immune checkpoint-based therapeutics for atherosclerosisJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:3f655ca0-9f50-4910-86d3-c1b4f2af2b3fEnglishSymplectic ElementsOxford University Press2023Lutgens, EMulder, WJMMonaco, CCHECKPOINT ATHERO consortium
spellingShingle Lutgens, E
Mulder, WJM
Monaco, C
CHECKPOINT ATHERO: developing immune checkpoint-based therapeutics for atherosclerosis
title CHECKPOINT ATHERO: developing immune checkpoint-based therapeutics for atherosclerosis
title_full CHECKPOINT ATHERO: developing immune checkpoint-based therapeutics for atherosclerosis
title_fullStr CHECKPOINT ATHERO: developing immune checkpoint-based therapeutics for atherosclerosis
title_full_unstemmed CHECKPOINT ATHERO: developing immune checkpoint-based therapeutics for atherosclerosis
title_short CHECKPOINT ATHERO: developing immune checkpoint-based therapeutics for atherosclerosis
title_sort checkpoint athero developing immune checkpoint based therapeutics for atherosclerosis
work_keys_str_mv AT lutgense checkpointatherodevelopingimmunecheckpointbasedtherapeuticsforatherosclerosis
AT mulderwjm checkpointatherodevelopingimmunecheckpointbasedtherapeuticsforatherosclerosis
AT monacoc checkpointatherodevelopingimmunecheckpointbasedtherapeuticsforatherosclerosis